A Second Malignancy Is the Major Cause of Death among Thoracic Squamous Cell Esophageal Cancer Patients Negative for Lymph Node Involvement
The aim of the present study was to determine the major causes of death among esophageal cancer patients whose lymph nodes did not show metastasis at the time they received esophagectomy, and to consider strategies for improving survival rates among these patients. Between 1989 and 1999, 93 of our p...
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Surgeons 2005-08, Vol.201 (2), p.188-193 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 193 |
---|---|
container_issue | 2 |
container_start_page | 188 |
container_title | Journal of the American College of Surgeons |
container_volume | 201 |
creator | Sato, Yusuke Motoyama, Satoru Maruyama, Kiyotomi Okuyama, Manabu Ogawa, Junichi |
description | The aim of the present study was to determine the major causes of death among esophageal cancer patients whose lymph nodes did not show metastasis at the time they received esophagectomy, and to consider strategies for improving survival rates among these patients.
Between 1989 and 1999, 93 of our patients who underwent curative esophagectomy with extended lymph node dissection for thoracic squamous cell esophageal cancer showed no lymph node metastasis. We followed up these node-negative patients for as long as 10 years and determined the major causes of death.
Sixty-three patients were still alive after esophagectomy, although 30 had died. Six patients died within 3 years after esophagectomy as a direct result of recurrence of their esophageal cancer; 13 died as a result of a second (extraesophageal) malignancy. Within the first 3 years, the major causes of death were recurrence (35%) and the second malignancy (35%); thereafter, the major cause was only the second malignancy (54%). There was no difference in the survival rates among patients with earlier, synchronous, or subsequent malignancies. Univariate and multivariate analyses of the 10-year survival showed the independent prognostic factors to be recurrence of esophageal cancer and development of a second malignancy, which respectively increased the risk of death 6.4 and 2.7 times.
The major cause of reduced survival among thoracic squamous esophageal cancer patients, whose lymph nodes did not show metastasis, was a second malignancy. New strategies aimed at preventing or treating synchronous and subsequent malignancies could prolong the survival of these patients. |
doi_str_mv | 10.1016/j.jamcollsurg.2005.03.013 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68070759</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1072751505003261</els_id><sourcerecordid>68070759</sourcerecordid><originalsourceid>FETCH-LOGICAL-c471t-6739d5d98b35e15b81a58866a366ae59f0707e7209998246838a584586157b9a3</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhSMEoqXwCsgsYJdgx_HfsgoFRhoKUsva8jg3f3LiqZ2MNM_AS-PRjFSWLCxfXX33-vicLPtAcEEw4Z_HYjST9c7FNXRFiTErMC0woS-yayKFyglR-GWqsShzwQi7yt7EOGJMBFb8dXZFOKZSkuo6-3OLHsD6uUE_jBu62cz2iDYRLT2kzugDqs0aAfkWfQGz9MhMfu7QY--DsYNFD09r6qwR1eAcuot-35sOjEtjs4WAfpllgHmJ6B66VB4AtWnn9jjte3TvG0Cb-eDdAaYEvc1etcZFeHe5b7LfX-8e6-_59ue3TX27zW0lyJJzQVXDGiV3lAFhO0kMk5JzQ9MBplossABRYqWULCsuqUxAxSQnTOyUoTfZp_PeffBPK8RFT0O0Sb-ZIX1Fc3nawFQC1Rm0wccYoNX7MEwmHDXB-pSEHvU_SehTEhpTnZJIs-8vj6y7CZrnyYv1Cfh4AUy0xrUhGTbEZ05gUpbVSUR95iBZchgg6GiTpRaaIYBddOOH_5DzF4mPrJI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68070759</pqid></control><display><type>article</type><title>A Second Malignancy Is the Major Cause of Death among Thoracic Squamous Cell Esophageal Cancer Patients Negative for Lymph Node Involvement</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Sato, Yusuke ; Motoyama, Satoru ; Maruyama, Kiyotomi ; Okuyama, Manabu ; Ogawa, Junichi</creator><creatorcontrib>Sato, Yusuke ; Motoyama, Satoru ; Maruyama, Kiyotomi ; Okuyama, Manabu ; Ogawa, Junichi</creatorcontrib><description>The aim of the present study was to determine the major causes of death among esophageal cancer patients whose lymph nodes did not show metastasis at the time they received esophagectomy, and to consider strategies for improving survival rates among these patients.
Between 1989 and 1999, 93 of our patients who underwent curative esophagectomy with extended lymph node dissection for thoracic squamous cell esophageal cancer showed no lymph node metastasis. We followed up these node-negative patients for as long as 10 years and determined the major causes of death.
Sixty-three patients were still alive after esophagectomy, although 30 had died. Six patients died within 3 years after esophagectomy as a direct result of recurrence of their esophageal cancer; 13 died as a result of a second (extraesophageal) malignancy. Within the first 3 years, the major causes of death were recurrence (35%) and the second malignancy (35%); thereafter, the major cause was only the second malignancy (54%). There was no difference in the survival rates among patients with earlier, synchronous, or subsequent malignancies. Univariate and multivariate analyses of the 10-year survival showed the independent prognostic factors to be recurrence of esophageal cancer and development of a second malignancy, which respectively increased the risk of death 6.4 and 2.7 times.
The major cause of reduced survival among thoracic squamous esophageal cancer patients, whose lymph nodes did not show metastasis, was a second malignancy. New strategies aimed at preventing or treating synchronous and subsequent malignancies could prolong the survival of these patients.</description><identifier>ISSN: 1072-7515</identifier><identifier>EISSN: 1879-1190</identifier><identifier>DOI: 10.1016/j.jamcollsurg.2005.03.013</identifier><identifier>PMID: 16038814</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>Aftercare ; Aged ; Aged, 80 and over ; Analysis of Variance ; Biological and medical sciences ; Carcinoma, Squamous Cell - mortality ; Carcinoma, Squamous Cell - pathology ; Carcinoma, Squamous Cell - therapy ; Cause of Death ; Esophageal Neoplasms - mortality ; Esophageal Neoplasms - pathology ; Esophageal Neoplasms - therapy ; Esophagectomy ; Female ; Follow-Up Studies ; General aspects ; Health Services Needs and Demand ; Hospitals, University ; Humans ; Japan - epidemiology ; Lymph Node Excision ; Lymphatic Metastasis ; Male ; Medical sciences ; Middle Aged ; Morbidity ; Neoplasm Recurrence, Local - mortality ; Neoplasm Recurrence, Local - pathology ; Neoplasm Recurrence, Local - therapy ; Neoplasm Staging ; Neoplasms, Second Primary - mortality ; Neoplasms, Second Primary - pathology ; Neoplasms, Second Primary - therapy ; Prognosis ; Proportional Hazards Models ; Risk Factors ; Survival Analysis</subject><ispartof>Journal of the American College of Surgeons, 2005-08, Vol.201 (2), p.188-193</ispartof><rights>2005 American College of Surgeons</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c471t-6739d5d98b35e15b81a58866a366ae59f0707e7209998246838a584586157b9a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S1072751505003261$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306,69986</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17012249$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16038814$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sato, Yusuke</creatorcontrib><creatorcontrib>Motoyama, Satoru</creatorcontrib><creatorcontrib>Maruyama, Kiyotomi</creatorcontrib><creatorcontrib>Okuyama, Manabu</creatorcontrib><creatorcontrib>Ogawa, Junichi</creatorcontrib><title>A Second Malignancy Is the Major Cause of Death among Thoracic Squamous Cell Esophageal Cancer Patients Negative for Lymph Node Involvement</title><title>Journal of the American College of Surgeons</title><addtitle>J Am Coll Surg</addtitle><description>The aim of the present study was to determine the major causes of death among esophageal cancer patients whose lymph nodes did not show metastasis at the time they received esophagectomy, and to consider strategies for improving survival rates among these patients.
Between 1989 and 1999, 93 of our patients who underwent curative esophagectomy with extended lymph node dissection for thoracic squamous cell esophageal cancer showed no lymph node metastasis. We followed up these node-negative patients for as long as 10 years and determined the major causes of death.
Sixty-three patients were still alive after esophagectomy, although 30 had died. Six patients died within 3 years after esophagectomy as a direct result of recurrence of their esophageal cancer; 13 died as a result of a second (extraesophageal) malignancy. Within the first 3 years, the major causes of death were recurrence (35%) and the second malignancy (35%); thereafter, the major cause was only the second malignancy (54%). There was no difference in the survival rates among patients with earlier, synchronous, or subsequent malignancies. Univariate and multivariate analyses of the 10-year survival showed the independent prognostic factors to be recurrence of esophageal cancer and development of a second malignancy, which respectively increased the risk of death 6.4 and 2.7 times.
The major cause of reduced survival among thoracic squamous esophageal cancer patients, whose lymph nodes did not show metastasis, was a second malignancy. New strategies aimed at preventing or treating synchronous and subsequent malignancies could prolong the survival of these patients.</description><subject>Aftercare</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Analysis of Variance</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Carcinoma, Squamous Cell - therapy</subject><subject>Cause of Death</subject><subject>Esophageal Neoplasms - mortality</subject><subject>Esophageal Neoplasms - pathology</subject><subject>Esophageal Neoplasms - therapy</subject><subject>Esophagectomy</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>General aspects</subject><subject>Health Services Needs and Demand</subject><subject>Hospitals, University</subject><subject>Humans</subject><subject>Japan - epidemiology</subject><subject>Lymph Node Excision</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Morbidity</subject><subject>Neoplasm Recurrence, Local - mortality</subject><subject>Neoplasm Recurrence, Local - pathology</subject><subject>Neoplasm Recurrence, Local - therapy</subject><subject>Neoplasm Staging</subject><subject>Neoplasms, Second Primary - mortality</subject><subject>Neoplasms, Second Primary - pathology</subject><subject>Neoplasms, Second Primary - therapy</subject><subject>Prognosis</subject><subject>Proportional Hazards Models</subject><subject>Risk Factors</subject><subject>Survival Analysis</subject><issn>1072-7515</issn><issn>1879-1190</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkc1u1DAUhSMEoqXwCsgsYJdgx_HfsgoFRhoKUsva8jg3f3LiqZ2MNM_AS-PRjFSWLCxfXX33-vicLPtAcEEw4Z_HYjST9c7FNXRFiTErMC0woS-yayKFyglR-GWqsShzwQi7yt7EOGJMBFb8dXZFOKZSkuo6-3OLHsD6uUE_jBu62cz2iDYRLT2kzugDqs0aAfkWfQGz9MhMfu7QY--DsYNFD09r6qwR1eAcuot-35sOjEtjs4WAfpllgHmJ6B66VB4AtWnn9jjte3TvG0Cb-eDdAaYEvc1etcZFeHe5b7LfX-8e6-_59ue3TX27zW0lyJJzQVXDGiV3lAFhO0kMk5JzQ9MBplossABRYqWULCsuqUxAxSQnTOyUoTfZp_PeffBPK8RFT0O0Sb-ZIX1Fc3nawFQC1Rm0wccYoNX7MEwmHDXB-pSEHvU_SehTEhpTnZJIs-8vj6y7CZrnyYv1Cfh4AUy0xrUhGTbEZ05gUpbVSUR95iBZchgg6GiTpRaaIYBddOOH_5DzF4mPrJI</recordid><startdate>20050801</startdate><enddate>20050801</enddate><creator>Sato, Yusuke</creator><creator>Motoyama, Satoru</creator><creator>Maruyama, Kiyotomi</creator><creator>Okuyama, Manabu</creator><creator>Ogawa, Junichi</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20050801</creationdate><title>A Second Malignancy Is the Major Cause of Death among Thoracic Squamous Cell Esophageal Cancer Patients Negative for Lymph Node Involvement</title><author>Sato, Yusuke ; Motoyama, Satoru ; Maruyama, Kiyotomi ; Okuyama, Manabu ; Ogawa, Junichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c471t-6739d5d98b35e15b81a58866a366ae59f0707e7209998246838a584586157b9a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Aftercare</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Analysis of Variance</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Carcinoma, Squamous Cell - therapy</topic><topic>Cause of Death</topic><topic>Esophageal Neoplasms - mortality</topic><topic>Esophageal Neoplasms - pathology</topic><topic>Esophageal Neoplasms - therapy</topic><topic>Esophagectomy</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>General aspects</topic><topic>Health Services Needs and Demand</topic><topic>Hospitals, University</topic><topic>Humans</topic><topic>Japan - epidemiology</topic><topic>Lymph Node Excision</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Morbidity</topic><topic>Neoplasm Recurrence, Local - mortality</topic><topic>Neoplasm Recurrence, Local - pathology</topic><topic>Neoplasm Recurrence, Local - therapy</topic><topic>Neoplasm Staging</topic><topic>Neoplasms, Second Primary - mortality</topic><topic>Neoplasms, Second Primary - pathology</topic><topic>Neoplasms, Second Primary - therapy</topic><topic>Prognosis</topic><topic>Proportional Hazards Models</topic><topic>Risk Factors</topic><topic>Survival Analysis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sato, Yusuke</creatorcontrib><creatorcontrib>Motoyama, Satoru</creatorcontrib><creatorcontrib>Maruyama, Kiyotomi</creatorcontrib><creatorcontrib>Okuyama, Manabu</creatorcontrib><creatorcontrib>Ogawa, Junichi</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of the American College of Surgeons</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sato, Yusuke</au><au>Motoyama, Satoru</au><au>Maruyama, Kiyotomi</au><au>Okuyama, Manabu</au><au>Ogawa, Junichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Second Malignancy Is the Major Cause of Death among Thoracic Squamous Cell Esophageal Cancer Patients Negative for Lymph Node Involvement</atitle><jtitle>Journal of the American College of Surgeons</jtitle><addtitle>J Am Coll Surg</addtitle><date>2005-08-01</date><risdate>2005</risdate><volume>201</volume><issue>2</issue><spage>188</spage><epage>193</epage><pages>188-193</pages><issn>1072-7515</issn><eissn>1879-1190</eissn><abstract>The aim of the present study was to determine the major causes of death among esophageal cancer patients whose lymph nodes did not show metastasis at the time they received esophagectomy, and to consider strategies for improving survival rates among these patients.
Between 1989 and 1999, 93 of our patients who underwent curative esophagectomy with extended lymph node dissection for thoracic squamous cell esophageal cancer showed no lymph node metastasis. We followed up these node-negative patients for as long as 10 years and determined the major causes of death.
Sixty-three patients were still alive after esophagectomy, although 30 had died. Six patients died within 3 years after esophagectomy as a direct result of recurrence of their esophageal cancer; 13 died as a result of a second (extraesophageal) malignancy. Within the first 3 years, the major causes of death were recurrence (35%) and the second malignancy (35%); thereafter, the major cause was only the second malignancy (54%). There was no difference in the survival rates among patients with earlier, synchronous, or subsequent malignancies. Univariate and multivariate analyses of the 10-year survival showed the independent prognostic factors to be recurrence of esophageal cancer and development of a second malignancy, which respectively increased the risk of death 6.4 and 2.7 times.
The major cause of reduced survival among thoracic squamous esophageal cancer patients, whose lymph nodes did not show metastasis, was a second malignancy. New strategies aimed at preventing or treating synchronous and subsequent malignancies could prolong the survival of these patients.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>16038814</pmid><doi>10.1016/j.jamcollsurg.2005.03.013</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1072-7515 |
ispartof | Journal of the American College of Surgeons, 2005-08, Vol.201 (2), p.188-193 |
issn | 1072-7515 1879-1190 |
language | eng |
recordid | cdi_proquest_miscellaneous_68070759 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Aftercare Aged Aged, 80 and over Analysis of Variance Biological and medical sciences Carcinoma, Squamous Cell - mortality Carcinoma, Squamous Cell - pathology Carcinoma, Squamous Cell - therapy Cause of Death Esophageal Neoplasms - mortality Esophageal Neoplasms - pathology Esophageal Neoplasms - therapy Esophagectomy Female Follow-Up Studies General aspects Health Services Needs and Demand Hospitals, University Humans Japan - epidemiology Lymph Node Excision Lymphatic Metastasis Male Medical sciences Middle Aged Morbidity Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - pathology Neoplasm Recurrence, Local - therapy Neoplasm Staging Neoplasms, Second Primary - mortality Neoplasms, Second Primary - pathology Neoplasms, Second Primary - therapy Prognosis Proportional Hazards Models Risk Factors Survival Analysis |
title | A Second Malignancy Is the Major Cause of Death among Thoracic Squamous Cell Esophageal Cancer Patients Negative for Lymph Node Involvement |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T09%3A52%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Second%20Malignancy%20Is%20the%20Major%20Cause%20of%20Death%20among%20Thoracic%20Squamous%20Cell%20Esophageal%20Cancer%20Patients%20Negative%20for%20Lymph%20Node%20Involvement&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Surgeons&rft.au=Sato,%20Yusuke&rft.date=2005-08-01&rft.volume=201&rft.issue=2&rft.spage=188&rft.epage=193&rft.pages=188-193&rft.issn=1072-7515&rft.eissn=1879-1190&rft_id=info:doi/10.1016/j.jamcollsurg.2005.03.013&rft_dat=%3Cproquest_cross%3E68070759%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68070759&rft_id=info:pmid/16038814&rft_els_id=S1072751505003261&rfr_iscdi=true |